Atai Life Sciences N.V.

NASDAQ: ATAI · Real-Time Price · USD
3.88
-0.13 (-3.24%)
At close: Aug 15, 2025, 3:59 PM
3.88
-0.13%
After-hours: Aug 15, 2025, 07:51 PM EDT

Atai Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-149.8M -150.05M -129.35M -58.94M -35.4M -43.05M -71.4M -150.48M -154.21M -157.42M -204.04M -199.98M -215.85M -174.24M -175.33M -226.88M -190.46M
Depreciation & Amortization
606K 473K 349K 340K 337K 319K 271K 233K 173K 168K 144K 101K 101K 47K 32K 44K 28K
Stock-Based Compensation
23.09M 25.49M 24.39M 27.6M 30.08M 32.98M 37.82M 40.08M 40.83M 42.38M 43.63M 45.36M 73.36M 63.36M 114.9M 104.8M 67.33M
Other Working Capital
2.11M -2.16M 3.29M 838.71K -164.76K 1.63M -5.37M -4.14M -3.21M -301K -547K -1.24M 17.63M -9.9M -3.23M -2.89M -24.14M
Other Non-Cash Items
46.81M 56.79M 42.4M 37.94M 6.19M -2.93M 4.28M 930K 4.77M 8.67M 11.93M 14.39M 19.98M 16.06M 26.38M 40.66M 32.56M
Deferred Income Tax
n/a n/a -8.5M -79.39M -77.98M -77.98M -64.41M 6.48M 5.07M 5.07M 52.87M 49.5M 37.47M 39.13M -11.1M 54.15M 76M
Change in Working Capital
-4.18M -9.19M -2.59M 780.68K -1.28M 7.4M 787K 480K 1.78M -3.33M 988K -3.91M 14.23M -7.6M -3.84M 939K -18.85M
Operating Cash Flow
-77.7M -82.44M -79.24M -78.33M -84.72M -83.26M -92.66M -102.28M -101.59M -104.47M -94.47M -94.54M -70.71M -63.25M -48.95M -26.29M -33.4M
Capital Expenditures
-90K -95K -16.04K -17.04K -145.04K -583.04K -796K -1.32M -1.41M -1.02M -1.16M -947K -1.01M -1.13M -821K -504K -229K
Cash Acquisitions
359K 359K 37K 39K 196K 196K 171.28M 77.22M 77.06M -134.62M -353.31M -259.26M -264.15M -52.94M -7.45M -12.79M -7.99M
Purchase of Investments
26.36M -5M -5.32M -240.4M -214.45M -183.09M -230.28M -119.6M -97.98M -309.66M -257.15M -229.89M -234.58M -23.66M -24.41M -29.54M -6.95M
Sales Maturities Of Investments
39.89M 83.73M 79.44M 228.76M 162.23M 137.85M 263.63M 264.04M 246.29M 226.83M 96.47M 1.92M 1.77M 1.77M -650K 5.19M 5.43M
Other Investing Acitivies
-17.33M -7.31M -9.13M -7.28M -5.04M -7.04M -176.25M -80.22M -79.98M -79.98M 88.01M -5.63M -6M -5.32M -3.17M -3.62M -3.53M
Investing Cash Flow
36.69M 59.17M 52.42M -18.9M -57.21M -52.66M 27.58M 140.12M 143.91M -86.85M -215.53M -282.2M -292.29M -81.28M -36.51M -41.27M -13.27M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a 15M 15M 15M 15M n/a -1.58M 1.59M 3.02M 21.08M 25.87M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
65.54M 5.37M -3.26M -8.15M -8.58M -8.37M -1.15M 3.63M 5.53M 5.45M 8.43M 7.53M -434K -1.61M -5.22M -9.1M -2.93M
Financial Cash Flow
64.98M 5.37M -3.24M -8.14M -8.56M -8.36M -816.05K 18.96M 20.86M 20.79M 23.43M 7.53M 379.5M 409.86M 490.12M 504.3M 133.74M
Net Cash Flow
24.42M -27.53M -41.53M -116.76M -162.02M -145.58M -66.05M 56.96M 61.91M -171.65M -287.77M -369.49M 19.61M 265.02M 407.6M 438.89M 87.42M
Free Cash Flow
-77.8M -82.53M -79.26M -78.35M -84.86M -83.84M -93.46M -103.6M -103M -105.49M -95.63M -95.48M -71.72M -64.37M -49.77M -26.79M -33.63M